Author(s): Anny Setijo Rahaju, Arifa Mustika, Priangga Adi Wiratama, Lukman Hakim, Doddy M. Soebadi

Email(s): anny_sr@fk.unair.ac.id

DOI: 10.52711/0974-360X.2023.00214

Address: Anny Setijo Rahaju1,2,3,4*, Arifa Mustika5, Priangga Adi Wiratama2,4, Lukman Hakim3,4,6, Doddy M. Soebadi4,6
1Doctoral Program in Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
2Department of Anatomical Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
3Universitas Airlangga Teaching Hospital, Surabaya, Indonesia.
4Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
5Divison Pharmacology and Therapy, Department of Anatomy, Histology, and Pharmacology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
6Department of Urology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
*Corresponding Author

Published In:   Volume - 16,      Issue - 3,     Year - 2023


Cite this article:
Anny Setijo Rahaju, Arifa Mustika, Priangga Adi Wiratama, Lukman Hakim, Doddy M. Soebadi. Antitumor activity of Metformin through p53 and Cyclin D1 in the Urothelial Cell Carcinoma. Research Journal of Pharmacy and Technology 2023; 16(3):1303-8. doi: 10.52711/0974-360X.2023.00214




Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available